Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Jun;84(11):3619–3622. doi: 10.1073/pnas.84.11.3619

Regulation of insulin-like growth factor II receptors by growth hormone and insulin in rat adipocytes.

P Lönnroth, K Assmundsson, S Edén, G Enberg, I Gause, K Hall, U Smith
PMCID: PMC304926  PMID: 2954159

Abstract

The acute and long-term effects of growth hormone (GH) on the binding of insulin-like growth factor II (IGF-II) were evaluated in adipose cells from hypophysectomized rats given replacement therapy with thyroxine and hydrocortisone and in cells from their sham-operated littermates. After the cells were incubated with insulin and/or GH, the recycling of IGF-II receptors was metabolically inhibited by treating the cells with KCN. IGF-II binding was 100 +/- 20% higher in cells from GH-deficient animals when compared with sham-operated controls. These GH-deficient cells also showed an increased sensitivity for insulin as compared with control cells (the EC50 for insulin was 0.06 ng/ml in GH-deficient cells and 0.3 ng/ml in control cells). However, the maximal incremental effect of insulin on IGF-II binding was reduced approximately 27% by hypophysectomy. GH added to the incubation medium increased the number of IGF-II binding sites by 100 +/- 18% in cells from hypophysectomized animals. This increase was rapidly induced (t1/2, approximately 10 min), but the time course was slower than that for the stimulatory effect of insulin. Half-maximal effect of GH on IGF-II binding was obtained at approximately equal to 10 ng/ml. Thus, GH added in vitro exerted a rapid insulin-like effect on the number of IGF-II receptors. GH also appears to play a regulating role for maintaining the cellular number of IGF-II receptors and, in addition, modulates the stimulatory effect of insulin on IGF-II binding.

Full text

PDF
3619

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams S. O., Nissley S. P., Handwerger S., Rechler M. M. Developmental patterns of insulin-like growth factor-I and -II synthesis and regulation in rat fibroblasts. Nature. 1983 Mar 10;302(5904):150–153. doi: 10.1038/302150a0. [DOI] [PubMed] [Google Scholar]
  2. Björgell P., Rosberg S., Isaksson O., Belfrage P. The antilipolytic, insulin-like effect of growth hormone is caused by a net decrease of hormone-sensitive lipase phosphorylation. Endocrinology. 1984 Sep;115(3):1151–1156. doi: 10.1210/endo-115-3-1151. [DOI] [PubMed] [Google Scholar]
  3. Clemmons D. R., Underwood L. E., Van Wyk J. J. Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts. J Clin Invest. 1981 Jan;67(1):10–19. doi: 10.1172/JCI110001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conover C. A., Dollar L. A., Hintz R. L., Rosenfeld R. G. Insulin-like growth factor I/somatomedin-C (IGF-I/SM-C) and glucocorticoids synergistically regulate mitosis in competent human fibroblasts. J Cell Physiol. 1983 Aug;116(2):191–197. doi: 10.1002/jcp.1041160210. [DOI] [PubMed] [Google Scholar]
  5. Cushman S. W., Wardzala L. J. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem. 1980 May 25;255(10):4758–4762. [PubMed] [Google Scholar]
  6. Dainiak N., Kreczko S. Interactions of insulin, insulinlike growth factor II, and platelet-derived growth factor in erythropoietic culture. J Clin Invest. 1985 Sep;76(3):1237–1242. doi: 10.1172/JCI112079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DiGirolamo M., Edén S., Enberg G., Isaksson O., Lönnroth P., Hall K., Smith U. Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes. FEBS Lett. 1986 Sep 1;205(1):15–19. doi: 10.1016/0014-5793(86)80856-0. [DOI] [PubMed] [Google Scholar]
  8. Enberg G., Carlquist M., Jörnvall H., Hall K. The characterization of somatomedin A, isolated by microcomputer-controlled chromatography, reveals an apparent identity to insulin-like growth factor 1. Eur J Biochem. 1984 Aug 15;143(1):117–124. doi: 10.1111/j.1432-1033.1984.tb08349.x. [DOI] [PubMed] [Google Scholar]
  9. Enberg G., Tham A., Sara V. R. The influence of purified somatomedins and insulin on foetal rat brain DNA synthesis in vitro. Acta Physiol Scand. 1985 Oct;125(2):305–308. doi: 10.1111/j.1748-1716.1985.tb07720.x. [DOI] [PubMed] [Google Scholar]
  10. Fagin K. D., Lackey S. L., Reagan C. R., DiGirolamo M. Specific binding of growth hormone by rat adipocytes. Endocrinology. 1980 Aug;107(2):608–615. doi: 10.1210/endo-107-2-608. [DOI] [PubMed] [Google Scholar]
  11. Gause I., Eden S., Jansson J. O., Isaksson O. Effects of in vivo administration of antiserum to rat growth hormone on body growth and insulin responsiveness in adipose tissue. Endocrinology. 1983 May;112(5):1559–1566. doi: 10.1210/endo-112-5-1559. [DOI] [PubMed] [Google Scholar]
  12. Gause I., Isaksson O., Lindahl A., Edén S. Effect of insulin treatment of hypophysectomized rats on adipose tissue responsiveness to insulin and growth hormone. Endocrinology. 1985 Mar;116(3):945–951. doi: 10.1210/endo-116-3-945. [DOI] [PubMed] [Google Scholar]
  13. Goodman H. M., Kostyo J. L. Altered profiles of biological activity of growth hormone fragments on adipocyte metabolism. Endocrinology. 1981 Feb;108(2):553–558. doi: 10.1210/endo-108-2-553. [DOI] [PubMed] [Google Scholar]
  14. Green H., Morikawa M., Nixon T. A dual effector theory of growth-hormone action. Differentiation. 1985;29(3):195–198. doi: 10.1111/j.1432-0436.1985.tb00316.x. [DOI] [PubMed] [Google Scholar]
  15. Grichting G., Levy L. K., Goodman H. M. Relationship between binding and biological effects of human growth hormone in rat adipocytes. Endocrinology. 1983 Sep;113(3):1111–1120. doi: 10.1210/endo-113-3-1111. [DOI] [PubMed] [Google Scholar]
  16. Isaksson O. G., Schwartz J., Kostyo J. L., Reagan C. R. Use of antibodies to modify the effect of growth hormone on sugar transport in rat diaphragm muscle. Endocrinology. 1979 Aug;105(2):452–458. doi: 10.1210/endo-105-2-452. [DOI] [PubMed] [Google Scholar]
  17. King G. L., Kahn C. R., Rechler M. M., Nissley S. P. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor. J Clin Invest. 1980 Jul;66(1):130–140. doi: 10.1172/JCI109826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kono T., Robinson F. W., Sarver J. A., Vega F. V., Pointer R. H. Actions of insulin in fat cells. Effects of low temperature, uncouplers of oxidative phosphorylation, and respiratory inhibitors. J Biol Chem. 1977 Apr 10;252(7):2226–2233. [PubMed] [Google Scholar]
  19. Mottola C., Czech M. P. The type II insulin-like growth factor receptor does not mediate increased DNA synthesis in H-35 hepatoma cells. J Biol Chem. 1984 Oct 25;259(20):12705–12713. [PubMed] [Google Scholar]
  20. Reagan C. R., Kostyo J. L., Mills J. B., Moseley M. H., Wilhelmi A. E. Isolation and characterization of fragments of reduced and S-carbamidomethylated human growth hormone produced by plasmin digestion. II. Biological and immunological activities. Endocrinology. 1978 May;102(5):1377–1386. doi: 10.1210/endo-102-5-1377. [DOI] [PubMed] [Google Scholar]
  21. Rechler M. M., Nissley S. P., King G. L., Moses A. C., Van Obberghen-Schilling E. E., Romanus J. A., Knight A. B., Short P. A., White R. M. Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulin. J Supramol Struct Cell Biochem. 1981;15(3):253–286. doi: 10.1002/jsscb.1981.380150305. [DOI] [PubMed] [Google Scholar]
  22. Rechler M. M., Podskalny J. M., Nissley S. P. Interaction of multiplication-stimulating activity with chick embryo fibroblasts demonstrates a growth receptor. Nature. 1976 Jan 15;259(5539):134–136. doi: 10.1038/259134a0. [DOI] [PubMed] [Google Scholar]
  23. Schoenle E., Zapf J., Froesch E. R. Regulation of rat adipocyte glucose transport by growth hormone: no mediation by insulin-like growth factors. Endocrinology. 1983 Jan;112(1):384–386. doi: 10.1210/endo-112-1-384. [DOI] [PubMed] [Google Scholar]
  24. Smith U., Sjöström L., Björnstorp P. Comparison of two methods for determining human adipose cell size. J Lipid Res. 1972 Nov;13(6):822–824. [PubMed] [Google Scholar]
  25. Suzuki K., Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci U S A. 1980 May;77(5):2542–2545. doi: 10.1073/pnas.77.5.2542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vetter U., Zapf J., Heit W., Helbing G., Heinze E., Froesch E. R., Teller W. M. Human fetal and adult chondrocytes. Effect of insulinlike growth factors I and II, insulin, and growth hormone on clonal growth. J Clin Invest. 1986 Jun;77(6):1903–1908. doi: 10.1172/JCI112518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wardzala L. J., Simpson I. A., Rechler M. M., Cushman S. W. Potential mechanism of the stimulatory action of insulin on insulin-like growth factor II binding to the isolated rat adipose cell. Apparent redistribution of receptors cycling between a large intracellular pool and the plasma membrane. J Biol Chem. 1984 Jul 10;259(13):8378–8383. [PubMed] [Google Scholar]
  28. Zapf J., Schoenle E., Froesch E. R. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem. 1978 Jun 15;87(2):285–296. doi: 10.1111/j.1432-1033.1978.tb12377.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES